Articles with "lsl yfp" as a keyword



Photo by nightcrawler1986 from unsplash

Abstract 22: A new transgenic mouse model to explore the role of Cripto signaling in lethal prostate cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-22

Abstract: Introduction: Prostate cancer (PCa) at its early stages is treated with surgery or androgen-deprivation therapy, but PCa can turn castration resistant possibly due to pre-existing stem cell-like cells that reinitiate tumor growth and lead to… read more here.

Keywords: role; prostate; cripto; lsl yfp ... See more keywords
Photo by 20164rhodi from unsplash

Abstract A45: Loss of Adar1 in pancreatic acinar cells leads to cell apoptosis and inflammation

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer Research"

DOI: 10.1158/1538-7445.panca19-a45

Abstract: While genetic mutations have been shown to drive pancreatic ductal adenocarcinoma (PDAC), epigenomic alterations in cancer cells may also contribute to tumor initiation and progression. Adenosine-to-inosine (A-to-I) editing is the most common type of RNA… read more here.

Keywords: lsl yfp; loss; cancer; adar1 ... See more keywords
Photo by nci from unsplash

Abstract A044: Generation of a new mouse model to study the role of oncofetal Cripto in aggressive lethal prostate cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.prca2023-a044

Abstract: Introduction: Early stages of prostate cancer (PCa) are commonly treated with surgery and androgen-deprivation therapy, but PCa can turn castration resistant due to pre-existing stem cell-like cells which might re-initiate tumor growth and lead to… read more here.

Keywords: prostate cancer; role; cripto; lsl yfp ... See more keywords